Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial-Reference-Cited by-同舟云学术

Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial

Published:2020-10 Issue:8 Volume:16 Page:645-653
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Smits Pieter C.,Chang Chun Chin,Chevalier Bernard,West Nick E.J.,Gori Tommaso,Barbato Emanuele,Tarantini Giuseppe,Kocka Viktor,Achenbach Stephan,Dudek Dariusz,Escaned Javier,Wlodarczak Adrian,Abdel-Wahab Mohamed,Esposito Giovanni,Tijssen Jan G.P.,Morice Marie-Claude,Onuma Yoshinobu,van Geuns Robert-Jan M.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial;Frontiers in Cardiovascular Medicine;2024-09-10

2. Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies;Life Sciences;2024-09

3. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

4. Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry;REC: interventional cardiology (English Edition);2024-07-19

5. 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease;Current Problems in Cardiology;2024-06